About this trial
This study investigates how antidepressant pharmacotherapy, cognitive-behavioral therapy, or their combination modulate the temporal dynamics and connectivity of depressive symptom networks. Using intensive longitudinal ecological momentary assessment data, the trial examines treatment-specific changes in symptom interactions.
By applying network-based analytic approaches, the study aims to elucidate differential and potentially complementary mechanisms of change across treatment modalities. Findings may contribute to more informed and individualized treatment strategies for major depressive disorder.
Eligibility criteria
Qualifiers
Depressive disorder (mild to moderate symptom severity)
18-65 years
must own a smartphone with internet access
Disqualifiers
severe depressive episode
acute suicidality,
bipolar disorder,
substance use disorder
Trial design
Treatments tested in this trial
- Psychopharmacological treatment
- Cognitive-behavioral group treatment (CBGT-D)
Treatment groups
Sponsors and collaborators
Goethe University
Lead sponsor
Johann Wolfgang Goethe University Hospital
Collaborator
Philipps University Marburg
Collaborator